Log In
CQMS
Make a Donation
Log In
Donate
TROG 2026 ASM: Early Bird Registration now open
Our Km's for Cancer Research challenge is underway - join now
Click Here
$1.9 million grant sees TROG bring international trial to Australia
Click Here
Apply now for Attendance Grants for our 2026 ASM
Click Here

TROG 95.01 – Rectal Cancer

Completed
Gastrointestinal

A Randomised Trial Comparing Adjuvant Protracted Venous Infusion and Bolus 5FU/Leucovorin with Either Early or Late Radiotherapy in Rectal Caner

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 95.02 – Proctitis – Rectal Sucralfate

Next Post

TROG 94.01/AGITG IG9401 – Oesophagus – Localised Resectable (IG9401)

Related Post

Prof Wee Loon Ong
24 September, 2025

Prostate Cancer Month: Focus on the TROG Genitourinary Working Party

To mark Prostate Cancer Month in September, we asked

24 September, 2025

TROG members and staff celebrate World Radiotherapy Awareness Day

LATEST NEWS: 24 September 2025 TROG Cancer Research staff